- ISIN
- US8789721086
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jun 21, 2018
Highlights
- Market Cap
- $569.45M
- Enterprise Value
- $338.62M
- EPS (TTM)
- -$4.48
- EBITDA (TTM)
- -$83.24M
- Year Range
- $14.39 - $36.03
- Target Price
- $67.50
- ROA (TTM)
- -33.86%
- ROE (TTM)
- -36.23%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TECX Performance Chart
Tectonic Therapeutic, Inc (TECX) is up 45.5% since the beginning of the year. At $30 per share, TECX is trading 15.8% below its 52-week high of $36. Investors who bought $1,000 worth of TECX shares 5 years ago would now be looking at an investment worth $272.
Loading charts...
Returns By Period
Tectonic Therapeutic, Inc (TECX) has returned 45.45% so far this year and 53.15% over the past 12 months.
Tectonic Therapeutic, Inc
- 1D
- 1.07%
- 1M
- 4.19%
- YTD
- 45.45%
- 6M
- 41.71%
- 1Y
- 53.15%
- 3Y*
- 40.06%
- 5Y*
- -22.95%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
TECX Monthly Returns History
Based on dividend-adjusted daily data since Jun 21, 2018, TECX's average daily return is +0.07%, while the average monthly return is +0.17%. At this rate, an investment would double in approximately 34.0 years.
Historically, 48% of months were positive and 52% were negative. The best month was Jul 2023 with a return of +63.1%, while the worst month was Feb 2025 at -53.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.
On a daily basis, TECX closed higher 46% of trading days. The best single day was Jan 30, 2025 with a return of +113.2%, while the worst single day was Oct 1, 2018 at -51.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.17% | 17.31% | 31.81% | -9.51% | 11.42% | -2.65% | 45.45% | ||||||
| 2025 | 17.26% | -53.31% | -29.94% | 17.79% | 3.12% | -7.62% | 11.68% | 15.10% | -38.57% | 16.32% | 17.48% | -2.71% | -54.82% |
| 2024 | -7.35% | 3.97% | -2.29% | -7.03% | 24.37% | -7.26% | 8.80% | 7.14% | 57.81% | 35.41% | 21.33% | -7.25% | 182.90% |
| 2023 | 27.65% | 53.85% | -28.57% | -0.16% | 10.18% | -13.63% | 63.14% | -1.94% | 1.32% | 3.25% | -16.98% | 3.03% | 90.77% |
| 2022 | -49.61% | -25.26% | -8.97% | -30.08% | 5.32% | -5.35% | -1.04% | 4.35% | -32.37% | 5.90% | 33.58% | -21.56% | -81.48% |
| 2021 | 2.65% | -23.13% | 15.36% | -7.96% | -23.03% | -1.11% | -17.21% | -9.51% | -16.22% | 0.72% | -31.67% | 0.26% | -72.38% |
Benchmark Metrics
Tectonic Therapeutic, Inc has an annualized alpha of -1.58%, beta of 1.29, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since June 21, 2018.
- This stock participated in 195.56% of S&P 500 Index downside but only 73.08% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -1.58%
- Beta
- 1.29
- R²
- 0.06
- Upside Capture
- 73.08%
- Downside Capture
- 195.56%
Return for Risk
Risk / Return Rank
TECX ranks 65 for risk / return — better than 65% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Tectonic Therapeutic, Inc (TECX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TECX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.36 | ||
| Sortino ratioReturn per unit of downside risk | -1.35 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.37 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 1.20 | 2.78 | -1.59 |
| Martin ratioReturn relative to average drawdown | 2.31 | 12.44 | -10.13 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Tectonic Therapeutic, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tectonic Therapeutic, Inc was 98.90%, occurring on May 17, 2023. The portfolio has not yet recovered.
The current Tectonic Therapeutic, Inc drawdown is 95.20%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -98.90%May 2023 | 4y 7mo | — | 7y 9moSep 2018 - now |
Rate-hike selloffLate 2018 | -23.18%Sep 2018 | 22d | 13d | 1mo 5dAug 2018 - Sep 2018 |
2018 correction2018 | -19.17%Jul 2018 | 1d | 14d | 15dJul 2018 - Aug 2018 |
2018 correction2018 | -13.62%Jul 2018 | 11d | 15d | 26dJun 2018 - Jul 2018 |
Drawdown Indicators
| TECX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.90% | -56.78% | -42.12% |
Max Drawdown (1Y)Largest decline over 1 year | -44.62% | -9.10% | -35.52% |
Max Drawdown (3Y)Largest decline over 3 years | -73.25% | -18.90% | -54.35% |
Max Drawdown (5Y)Largest decline over 5 years | -94.17% | -25.43% | -68.74% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -95.20% | -1.80% | -93.40% |
Average DrawdownAverage peak-to-trough decline | -83.34% | -10.71% | -72.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.13% | 2.03% | +21.10% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Tectonic Therapeutic, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Tectonic Therapeutic, Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TECX in comparison with other companies in the Biotechnology industry. Currently, TECX has a P/B value of 2.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TECX
Add Tectonic Therapeutic, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TECX